LMO4
Basic information
Region (hg38): 1:87328880-87348923
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LMO4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 6 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 6 | 0 | 0 |
Variants in LMO4
This is a list of pathogenic ClinVar variants found in the LMO4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-87332106-G-T | not specified | Uncertain significance (Apr 13, 2022) | ||
1-87332215-A-G | not specified | Uncertain significance (Oct 04, 2022) | ||
1-87332247-A-G | not specified | Uncertain significance (Oct 29, 2021) | ||
1-87339616-A-G | not specified | Uncertain significance (May 24, 2023) | ||
1-87340069-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
1-87340153-A-G | not specified | Uncertain significance (Jun 16, 2023) | ||
1-87340180-A-G | not specified | Uncertain significance (Mar 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LMO4 | protein_coding | protein_coding | ENST00000370544 | 4 | 20456 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.677 | 0.319 | 125683 | 0 | 1 | 125684 | 0.00000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.10 | 43 | 103 | 0.418 | 0.00000555 | 1086 |
Missense in Polyphen | 9 | 38.813 | 0.23188 | 415 | ||
Synonymous | -0.899 | 51 | 43.5 | 1.17 | 0.00000257 | 316 |
Loss of Function | 2.29 | 1 | 7.97 | 0.125 | 3.39e-7 | 93 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Probable transcriptional factor. {ECO:0000250}.;
- Pathway
- SHP2 signaling;Validated nuclear estrogen receptor alpha network;IL6-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- loftool
- rvis_EVS
- -0.25
- rvis_percentile_EVS
- 35.42
Haploinsufficiency Scores
- pHI
- 0.442
- hipred
- Y
- hipred_score
- 0.806
- ghis
- 0.618
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.185
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lmo4
- Phenotype
- craniofacial phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; vision/eye phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- lmo4a
- Affected structure
- nucleate erythrocyte
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- neural tube closure;ventricular septum development;transcription by RNA polymerase II;ventral spinal cord interneuron differentiation;spinal cord motor neuron differentiation;spinal cord association neuron differentiation;regulation of cell migration;negative regulation of protein complex assembly;positive regulation of kinase activity;regulation of cell fate specification;positive regulation of transcription by RNA polymerase II;thymus development;regulation of cell activation
- Cellular component
- transcription factor complex;cell leading edge
- Molecular function
- enhancer sequence-specific DNA binding;DNA-binding transcription factor activity;protein binding;transcription factor binding;metal ion binding